Pharmacy Practice
Affordable Medicines
Biosimilars
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COVID-19
Dermatology
Diabetes
Gastroenterology
Hematology
HIV/AIDS
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Schizophrenia
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
COVID-19 Resources
DRUG APPROVALS
April 18, 2024
An Introduction to Some Newer and Restricted Antibiotics
Many of these agents may be restricted to use by infectious-disease physicians or by antimicrobial-stewardship teams, with pharmacists playing an important role.
April 18, 2024
COVID-19 Vaccines Past and Present
February 15, 2024
Colchicine Use in Atherosclerotic Cardiovascular Disease
January 18, 2024
Treating Genetic Obesity With the Novel Agent Setmelanotide
October 18, 2023
New Drug Review 2023
October 18, 2023
Trends in FDA-Approved Cancer Therapies
October 18, 2023
Bupropion 30 mg/mL Oral Suspension
October 18, 2023
Bempedoic Acid Use in Statin Intolerance
October 14, 2022
New Dual Incretin Agonist for Type 2 Diabetes
October 14, 2022
Review of Selected NMEs 2022
October 14, 2022
New Drug Review 2022
October 14, 2022
Novel Drug Approvals in the United States
June 16, 2022
Introduction to Two Recently Approved Insulin Glargine Biosimilars
Load More
X
April 2024
In This Issue
Digital Magazine
Archives
Subscription
×
Full Image